Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in Ireland.
In IrelandThis study is recruiting. It focuses on mental health and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in China.
In BeijingThis study is recruiting. It focuses on depression and currently lists participation information in Ireland, Portugal, and Spain.
In IrelandThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United Kingdom
This study is recruiting. It focuses on depression and currently lists participation information in China.
In Hong KongThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United States. It is testing ML-007C-MA for Schizophrenia.
Multiple locations, including DoralThis study is recruiting in the United Kingdom. It is testing Safety, Tolerability and Pharmacodynamics of BPL-003 for depression.
Multiple locations, including LiverpoolHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.